First Ever Drug Treatment for Aggressive Pediatric Bone Disease Nears FDA Approval

The FDA has accepted a new drug application for palovarotene, a drug identified by researchers at Children’s Hospital of Philadelphia to treat fibrodysplasia ossificans progressiva.